SCHEMBL660087

SCHEMBL660087

NCCCCNC(=O)NN

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 2/20 0.56
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
EPHX1 P07099 5/20 0.43
PRMT1 Q99873 1/20 0.41
GNAI3 P08754 1/20 0.41
GNAO1 P09471 1/20 0.41
GNAI1 P63096 1/20 0.41
CA12 O43570 1/20 0.40
F13A1 P00488 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CYP1A2 P05177 1/20 0.40
CA3 P07451 1/20 0.40
CYP2C9 P11712 1/20 0.40
PKM P14618 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19593402 0.90 EPHX1 (0.50) PAOXEPHX1PRMT1CA12CA1
SCHEMBL17373962 0.87 PAOX (0.62) PAOXMAOAMAOBEPHX1PRMT1
SCHEMBL17379928 0.87 PAOX (0.62) PAOXMAOAMAOBEPHX1PRMT1
SCHEMBL3139577 0.87 EPHX1 (0.54) PAOXEPHX1PRMT1SMN1; SMN2KDM4E
SCHEMBL12353013 0.85 PAOX (0.67) PAOXMAOAMAOBEPHX1PRMT1
SCHEMBL7209810 0.85 PAOX (0.67) PAOXMAOAMAOBEPHX1PRMT1
SCHEMBL15431680 0.85 PAOX (0.67) PAOXMAOAMAOBEPHX1PRMT1
SCHEMBL21695693 0.85 PAOX (0.67) PAOXMAOAMAOBEPHX1PRMT1
SCHEMBL7215969 0.85 PAOX (0.67) PAOXMAOAMAOBEPHX1PRMT1
SCHEMBL7210075 0.85 PAOX (0.67) PAOXMAOAMAOBEPHX1PRMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120045393-A1 LHRH-II PEPTIDE ANALOGS BRACCO IMAGING SPA (IT) 2012-02-23 US disclosed
US-20120045393-A1 LHRH-II PEPTIDE ANALOGS BRACCO IMAGING SPA (IT) 2012-02-23 US disclosed
US-20120045393-A1 LHRH-II PEPTIDE ANALOGS BRACCO IMAGING SPA (IT) 2012-02-23 US disclosed
WO-2010107832-A1 LHRH-II PEPTIDE ANALOGS BRACCO IMAGING SPA (IT) 2010-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120045393-A1 LHRH-II PEPTIDE ANALOGS LHCGR, GNRHR, FSHR PAOX 4096/4885MAOA 4770/4885MAOB 4480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.